Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Bullboard Posts
Comment by inthnoon Jun 12, 2009 2:56pm
519 Views
Post# 16066709

RE: This stock should run

RE: This stock should runI too believe that the stock could take a run....most of the people that have been in for a long time such as myself have always believed and stayed the course.
The momentum swing will start once they have fda approval for the phase 3 which will set onc on a new course.
Also, once we get more analysts involved in a more serious nature this will really help....
To top it off,of course is a partnering or buyout,but the timing of this will be very important....people are generally skeptical because no one can really believe that this might actually be the one and until someone big steps in....(big pharma and yes from the fda) there will always be that hesitation....
The time is a lot closer than most can really believe at this point...it has been a long road and now it is our turn.
Take care all
Bullboard Posts